Elekta Full Year 2024 Earnings: EPS Misses Expectations

Elekta (STO:EKTA B) Full Year 2024 Results

Key Financial Results

• Revenue: kr18.1b (up 7.4% from FY 2023).
• Net income: kr1.30b (up 38% from FY 2023).
• Profit margin: 7.2% (up from 5.6% in FY 2023). The increase in margin was driven by higher revenue.
• EPS: kr3.41 (up from kr2.47 in FY 2023).

All figures shown in the chart above are for the trailing 12 month (TTM) period

Elekta EPS Misses Expectations

Revenue was in line with analyst estimates. Earnings per share (EPS) missed analyst estimates by 12%.

The primary driver behind last 12 months revenue was the Europe, Middle East and Africa segment contributing a total revenue of kr6.55b (36% of total revenue). Notably, cost of sales worth kr11.3b amounted to 62% of total revenue thereby underscoring the impact on earnings. The largest operating expense was Sales & Marketing costs, amounting to kr1.64b (30% of total expenses). Explore how EKTA B's revenue and expenses shape its earnings.

Looking ahead, revenue is forecast to grow 6.1% p.a. on average during the next 3 years, compared to a 16% growth forecast for the Medical Equipment industry in Sweden.

Performance of the Swedish Medical Equipment industry.

The company's share price is broadly unchanged from a week ago.

Risk Analysis

You still need to take note of risks, for example - Elekta has 1 warning sign we think you should be aware of.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com